Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4026 Target Snapshot

Signal transducer and activator of transcription 3 · SINGLE PROTEIN · Homo sapiens

2,300Compounds
1,143Assays
7Approved Drugs
2,300.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P40763. Use UniProt P40763 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P40763 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Signal transducer and activator of transcription 3 as ChEMBL target CHEMBL4026, mapped to UniProt P40763. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Signal transducer and activator of transcription 3
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL4026
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P40763
Signal transducer and activator of transcription 3
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Signal transducer and activator of transcription 3 is the right protein anchor across sources, using UniProt P40763 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSignal transducer and activator of transcription 3
UniProt AccessionP40763
Component TypeProtein
Sequence Length770 aa

Signal transducer and activator of transcription 3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Signal transducer and activator of transcription 3, mapped to UniProt P40763. Sequence length is 770 aa.

Mapped IDP40763
Review nameSignal transducer and activator of transcription 3
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

7
Approved
8
Phase III
6
Phase II
Assay Mix

Activity Type Distribution

IC501,808.0
KI129.0
EC50303.0
KD60.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1389016 8.98 EC50 1.04 Preclinical
CHEMBL1449962 8.66 EC50 2.19 Preclinical
CHEMBL5437070 8.62 IC50 2.4 Preclinical
CHEMBL1703740 8.34 EC50 4.55 Preclinical
CHEMBL3392776 8.33 Kd 4.7 Clinical
CHEMBL4776801 8.29 Ki 5.1 Preclinical
CHEMBL5177956 8.28 IC50 5.3 Preclinical
CHEMBL5439447 8.23 IC50 5.9 Preclinical
CHEMBL5209107 8.23 IC50 5.9 Preclinical
CHEMBL5405538 8.15 IC50 7.0 Preclinical
Distribution

pChEMBL Value Distribution

498
5.0
227
5.5
196
6.0
118
6.5
69
7.0
26
7.5
11
8.0
3
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

DEUCRAVACITINIB
CHEMBL4435170
Approved 2022
BARICITINIB
CHEMBL2105759
Approved 2017
NICLOSAMIDE
CHEMBL1448
Approved 1982
DIGITOXIN
CHEMBL254219
Approved 1982
Assay Landscape

Assay Landscape

1,144
Total Assays
1,205
Tested Compounds
4
Assay Types
Binding — 1,130 assays, 1,205 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 895 547 5.7
single protein format 168 616 5.3
subcellular format 25 7 5.5
tissue-based format 25 3 4.8
assay format 17 32 6.2
Functional — 11 assays, 89 compounds
BAO Format Assays Compounds Avg pChEMBL
organism-based format 6 0
cell-based format 5 89 5.1
Unassigned — 2 assays, 17 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 2 17 6.1
ADME — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine